Trial NCT03518112

View at ClinicalTrials.gov 
Org. Study IDs: 2017-0127
Secondary IDs: 2017-0127 NCI-2018-00737

Last trial update was posted on 2022-11-04

MeSH Interventions

Antibodies Antibodies, Bispecific Antibodies, Monoclonal Antineoplastic Agents, Immunological BB 1101 Blinatumomab Calcium Calcium, Dietary Cyclophosphamide Cytarabine Dexamethasone Dexamethasone acetate Folic Acid Immunoglobulins Lenograstim Leucovorin Levoleucovorin Mercaptopurine Methotrexate Muromonab-CD3 Rituximab Vincristine

MeSH Conditions

Leukemia Leukemia, Lymphoid Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Philadelphia Chromosome Negative Recurrent B Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia

Stopping Reasons

Due to Competing Studies

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID